COMPARATIVE STUDY IN PHARINGITIS AND / OR ACUTE AMIGDALITIS OF CEFALEXIN VERSUS CEFADROXILO
- Conditions
- -J02-J03J02J03
- Registration Number
- PER-039-00
- Lead Sponsor
- ELI LILLY INTERAMERICA INC.,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Not specified
- Target Recruitment
- 0
• Patients from 2 years to 12 years of age.
• Diagnosis of acute pharyngitis or acute tonsillitis (<7 days duration)
• Rapid Strep positive test before starting treatment.
• The parent or legal representative must sign an informed consent document approved by a CE (Ethics Committee).
• The researcher will try to select those patients with a history of complying with the instructions received.
• Patients whose symptoms are due to evident viral infection of the upper respiratory tract.
• Researchers and their immediate family members are not allowed to be subjects or patients in studies sponsored by Lilly. As an immediate family member, the researcher´s spouse, parents, children, grandparents or grandchildren are defined.
• Persons who have previously completed this study or withdrawn from it will not be eligible to participate in this study.
• Reaction of severe hypersensitivity prior to cephalosporins or penicillin.
• Administration of systemic antibiotics in the 7 days prior to randomization.
• Inability to go to assessment consultation.
• Concomitant use of probenecid or concomitant treatment with corticosteroids.
• History of significant renal deterioration.
• Any condition that, in the opinion of the investigator, could impede the evaluation of the response.
• Patients who have received an agent in research (a drug that has not been approved for sale in the countries in which this study is conducted) as participants in a study, in the last 30 days.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method